Sectors
Mastercard, Intel, American Express and Santander could all exit the point-of-sale technology provider, which plans to float in Sweden.
The WuXi PharmaTech and Mayo Clinic-backed aging disease drug developer floated at the midpoint of its range.
China-based electronics producer Xiaomi has reportedly filed for an initial public offering at a $100bn valuation in Hong Kong.
The sleep apnea developer, backed by Medtronic and Johnson & Johnson, floated at the top of its range before seeing its stock rise 56% on the first day.
SoftBank is set to completely exit Flipkart as part of a deal that will value the company at $20bn, in which Alphabet is now expected to be involved.
Viking Global will take a majority stake in the cosmetics subscription service, once valued at $485m, wiping out other investors including Comcast Ventures.
The Qualcomm and NGP-backed electronics producer is reportedly seeking a $100bn valuation for the Hong Kong offering.
Radius, which is backed by Salesforce, Comcast, BBVA and Amex, has merged with fellow B2B marketing software provider Leadspace.
The corporate-backed pharmaceutical developers had aimed to raise a total of $155m from offerings they filed for in March.
The Kraft Group-backed spinal muscular atrophy drug developer has raised more than $100m in funding since 2012.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
